Search

Oxford Biomedica PLC

Cerrado

400.5 1.14

Resumen

Variación precio

24h

Actual

Mínimo

396

Máximo

404.5

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+27.59 upside

Oxford Biomedica PLC Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

1 nov 2024, 22:50 UTC

Acciones populares

Stocks to Watch: Nvidia, Intel, Sherwin-Williams, Dow, Nuwellis

1 nov 2024, 22:43 UTC

Principales Movimientos del Mercado

Nvidia, Sherwin-Williams Shares Up on Addition to DJIA

1 nov 2024, 22:13 UTC

Principales Movimientos del Mercado

Chewy Up 5% on S&P MidCap 400 Inclusion

1 nov 2024, 21:39 UTC

Ganancias

Insurance Company Chubb Projects Up to $300 Million Pre-Tax Loss on Hurricane

1 nov 2024, 22:51 UTC

Ganancias

Correction to Nvidia to Replace Intel in Dow Jones Industrial Average Article -- WSJ

1 nov 2024, 22:00 UTC

Principales Noticias
Ganancias

Nvidia to Replace Intel in Dow Jones Industrial Average. Sherwin-Williams Also Joins. -- WSJ

1 nov 2024, 21:29 UTC

Principales Noticias
Ganancias

Exxon and Chevron Feel Brunt of Cheaper Oil -- 2nd Update

1 nov 2024, 21:24 UTC

Ganancias

Insurance Company Chubb Projects Up to $300M Pre-Tax Loss on Hurricane

1 nov 2024, 20:57 UTC

Ganancias

BYD's Sales Hit a Record. It's Neck and Neck in EV Race With Tesla. -- Barrons.com

1 nov 2024, 20:50 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

1 nov 2024, 20:50 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

1 nov 2024, 20:48 UTC

Principales Noticias
Ganancias

Stocks Wrap Up Volatile Week With Gains -- WSJ

1 nov 2024, 20:44 UTC

Ganancias

AI Spending Dominated Big Tech Earnings. Why These 2 Stocks Got a Pass From Investors. -- Barrons.com

1 nov 2024, 20:10 UTC

Principales Noticias

Nasdaq, Dow Rebound After Jobs Report Disappoints -- WSJ

1 nov 2024, 19:47 UTC

Ganancias

Apple's Earnings Confirmed 1 Thing: Nobody Knows When a Major Upgrade Cycle Is Coming -- Barrons.com

1 nov 2024, 19:43 UTC

Charlas de Mercado

U.S. Natural Gas Ends Week Lower Awaiting Winter Weather -- Market Talk

1 nov 2024, 19:32 UTC

Charlas de Mercado

Oil Futures End Week With Losses -- Market Talk

1 nov 2024, 19:14 UTC

Principales Noticias

U.S. Job Growth Gradually Slowing Beyond Storm, Strike Disruptions - Analysis

1 nov 2024, 18:41 UTC

Charlas de Mercado

Mexican Manufacturing PMIs Point to Sluggish October -- Market Talk

1 nov 2024, 18:35 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

1 nov 2024, 18:35 UTC

Charlas de Mercado

November Fed Meeting Seen as Routine -- Market Talk

1 nov 2024, 18:33 UTC

Ganancias

These Stocks Are Moving the Most Today: Apple, Amazon, Intel, Boeing, Super Micro, Exxon, and More -- Barrons.com

1 nov 2024, 18:31 UTC

Charlas de Mercado

SPDR Gold Falls Late in Trading -- Market Talk

1 nov 2024, 18:06 UTC

Ganancias

Amazon's Big Spending Is Getting a Pass From Investors. Here's Why. -- Barrons.com

1 nov 2024, 18:02 UTC

Principales Noticias

U.S. Added Just 12,000 Jobs in October; Dow, Nasdaq Rally After Selloff -- WSJ

1 nov 2024, 17:46 UTC

Charlas de Mercado
Ganancias

Uber on Right Path to Achieve Mid-Term Targets -- Market Talk

1 nov 2024, 17:45 UTC

Principales Noticias

U.S. Added 12,000 Jobs in October as Storms Sidelined Workers -- 6th Update

1 nov 2024, 17:44 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

1 nov 2024, 17:44 UTC

Charlas de Mercado

McDonald's Can Recover From Short-Term Struggles, Analysts Say -- Market Talk

1 nov 2024, 17:33 UTC

Charlas de Mercado

Abbott's Baby-Formula Lawsuit Win Could Decrease Liabilities -- Market Talk

Oxford Biomedica PLC Esperado

Precio Objetivo

By TipRanks

27.59% repunte

Estimación a 12 meses

Media 516.748 GBX  27.59%

Máximo 776.276 GBX

Mínimo 398.628 GBX

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Oxford Biomedica PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Finanzas

$